CJRB-101

· CJ Bioscience, Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for CJRB-101, covering 2024-12-20 to 2024-12-20. Get the full timeline:

Most recent: Clinical Trial Update: Safety, Tolerability, and Preliminary Efficacy of CJRB-101 With Pembrolizumab in Subjects With Selected Types of Advanced or Metastatic Cancer [Phase 1, Phase 2]

See pricing